Cost-effectiveness of losartan in patients with hypertension and LVH in Spain: An economic evaluation based on the life trial

被引：1
|
作者：
Ruilope, LM
Burke, TA
Carides, GW
Nocea, G
机构：
[1] Hosp 12 Octubre, E-28041 Madrid, Spain
[2] Merck & Co Inc, Whitehouse Stn, NJ USA
[3] Merck Res Labs, Blue Bell, PA USA
[4] MSD Spain, Madrid, Spain
来源：
VALUE IN HEALTH | 2004年 / 7卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)65797-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：689 / 689
页数：1
相关论文
共 50 条
  • [21] The Rationale for Economic Evaluation in Speech and Language: Cost, Effectiveness, and Cost-effectiveness
    Hoch, Jeffrey S.
    Smith, Bridgette P.
    Kim, Jiyeong
    Dewa, Carolyn S.
    SEMINARS IN SPEECH AND LANGUAGE, 2022, 43 (03) : 208 - 217
  • [22] A Cost-effectiveness Analysis of Early Mobilization in Critically Ill Patients: An Economic Evaluation Alongside the Team Trial
    Higgins, A. M.
    Lee, Y.
    Broadley, T.
    Hodgson, C. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [23] Cost-effectiveness of monitoring glaucoma patients in shared care: an economic evaluation alongside a randomized controlled trial
    Kim M Holtzer-Goor
    Esther van Sprundel
    Hans G Lemij
    Thomas Plochg
    Niek S Klazinga
    Marc A Koopmanschap
    BMC Health Services Research, 10
  • [24] Cost-effectiveness of monitoring glaucoma patients in shared care: an economic evaluation alongside a randomized controlled trial
    Holtzer-Goor, Kim M.
    van Sprundel, Esther
    Lemij, Hans G.
    Plochg, Thomas
    Klazinga, Niek S.
    Koopmanschap, Marc A.
    BMC HEALTH SERVICES RESEARCH, 2010, 10
  • [25] Cost-effectiveness of alendronate in the treatment of oteoporosis in men in Canada -: An economic evaluation based on the fracture intervention trial
    Borgström, F
    Johnell, O
    Jönsson, B
    Desjardins, B
    Sen, SS
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S17 - S18
  • [26] QUALITY-OF-LIFE AND COST-EFFECTIVENESS IN THE TREATMENT OF HYPERTENSION
    WIKLUND, I
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1994, 19 (02) : 81 - 87
  • [27] Cost-effectiveness of raloxifene in the UK:: an economic evaluation based on the MORE study
    Kanis, JA
    Borgström, F
    Johnell, O
    Oden, A
    Sykes, D
    Jönsson, B
    OSTEOPOROSIS INTERNATIONAL, 2005, 16 (01) : 15 - 25
  • [28] Cost-effectiveness of raloxifene in the UK: an economic evaluation based on the MORE study
    J. A. Kanis
    F. Borgström
    O. Johnell
    A. Oden
    D. Sykes
    B. Jönsson
    Osteoporosis International, 2005, 16 : 15 - 25
  • [29] The cost-effectiveness of losartan versus captopril in patients with symptomatic heart failure
    Dasbach, EJ
    Rich, MW
    Segal, R
    Gerth, WC
    Carides, GW
    Cook, JR
    Murray, JF
    Snavely, DB
    Pitt, B
    CARDIOLOGY, 1999, 91 (03) : 189 - 194
  • [30] Cost-effectiveness analysis of febuxostat in patients with gout in Spain
    Perez-Ruiz, F.
    Diaz-Torne, C.
    Carcedo, D.
    JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (06) : 604 - 610
12345